FDA Inspection 1005657 — Taro Pharmaceutical Industries Ltd.
The FDA completed an inspection of Taro Pharmaceutical Industries Ltd. on Feb 5, 2017 in Haifa Bay. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 5, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Haifa Bay (Israel)